Full 3D Eye Modeling in the Diagnosis and Treatment of Lens Diseases With Eye Structures Disorders
1 other identifier
observational
1,200
1 country
1
Brief Summary
In patients with complex cataracts, spatial abnormalities in the lens and its surrounding tissues-including both the anterior and posterior ocular segments-are often present. Due to the lack of precise preoperative assessment tools and standardized surgical protocols, these cases are associated with increased surgical complexity and difficulty, often leading to suboptimal visual outcomes. Therefore, this study explores a three-dimensional reconstruction method for the anterior segment based on swept-source optical coherence tomography (SS-OCT). By integrating imaging data from CT, B-scan ultrasound, and ultrasound biomicroscopy (UBM), a full three-dimensional model of the eye is constructed to enable objective and quantitative evaluation of its entire structure. This approach aims to provide valuable reference for surgical planning and prognostic assessment in lens diseases accompanied by ocular spatial structural abnormalities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedFirst Submitted
Initial submission to the registry
December 7, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedFirst Posted
Study publicly available on registry
January 7, 2026
CompletedJanuary 7, 2026
November 1, 2025
6 years
December 7, 2025
December 22, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Anterior Segment SS-OCT Quantitative Results
Quantification of the anterior segment SS-OCT imaging results
Preoperatively, and postoperatively at 1 week, 1 month, and 3 months
Computed tomography
Quantification of ocular CT imaging results
Preoperatively, and postoperatively at 1 week, 1 month, and 3 months
B-scan ultrasonography
Quantification of the B-ultrasound imaging results of the eyes
Preoperatively, and postoperatively at 1 week, 1 month, and 3 months
Ultrasound Biomicroscope
Quantification of the results of ocular UBM examination
Preoperatively, and postoperatively at 1 week, 1 month, and 3 months
Secondary Outcomes (2)
IOL tilt decentration ELP
Preoperatively, and postoperatively at 1 week, 1 month, and 3 months
Surgical Record
During the operation
Study Arms (6)
Toward 3D Modeling for Lens Disorders Associated with Congenital Anomalies
Part I: Exploration and research on full three-dimensional modeling in the diagnosis and treatment of lens diseases with congenital developmental anomaliesa
Toward 3D Modeling for Reconstructive Management of Ocular Trauma
Part II: Exploration and research on full three-dimensional modeling for the reconstruction and treatment of ocular trauma
Toward 3D Modeling for IOL Spatial Positioning
Part III: Exploration and research on full three-dimensional modeling for the spatial positioning of pseudophakic eyes
Toward 3D Modeling for Cataracts with Iris/Pupillary Abnormalities
Part IV: Exploration and research on full three-dimensional modeling for cataract patients with iris or pupillary abnormalities
Toward 3D Modeling for Cataracts with Posterior Segment Diseases
Part V: Exploration and research on full three-dimensional modeling for the management and treatment of cataract patients with posterior segment diseases
Normal Control Group
Exploration and research on full three-dimensional modeling for individuals with no significant structural ocular diseases served as the normal control group.
Eligibility Criteria
The data for this project was collected from patients who visited the Second Affiliated Hospital, School of Medicine, Zhejiang University from January 1, 2020 to December 31, 2025.
You may qualify if:
- Part I:Toward 3D Modeling for Lens Disorders Associated with Congenital Anomalies
- \) Diagnosed with lens disorders such as lens subluxation or deformity via imaging (slit-lamp, UBM) or clinical examination, combined with conditions such as megalocornea, microcornea, nanophthalmos, keratoconus, or iris coloboma; 2) Presence of imageable ocular structures; 3) Able to cooperate with and complete relevant examinations including B-scan ultrasound, UBM, and anterior segment SS-OCT.
- Part II: Toward 3D Modeling for Reconstructive Management of Ocular Trauma 1) Diagnosed with previous or stabilized corneal trauma, traumatic cataract, or iris injury, with or without associated vitreous traction or retinal damage; 2) Patients with open globe injuries that have been managed, with closed wounds and no endophthalmitis; 3) Able to cooperate with and complete relevant examinations including B-scan ultrasound, UBM, anterior segment SS-OCT, and CT.
- Part III:Toward 3D Modeling for IOL Spatial Positioning 1) Patients who have undergone cataract extraction with intraocular lens (IOL) implantation (in-the-bag or scleral-fixated); 2) Stable IOL position post-implantation with clear documentation of IOL parameters; 3) Able to cooperate with and complete relevant examinations including B-scan ultrasound, UBM, and anterior segment SS-OCT.
- Part IV: Toward 3D Modeling for Cataracts with Iris/Pupillary Abnormalities
- Patients with iris morphological or positional abnormalities due to previous uveitis, trauma, or developmental anomalies (e.g., iris atrophy, synechiae, iridodialysis, polycoria, pupillary membrane remnants); 2) Able to cooperate with and complete relevant examinations including B-scan ultrasound, UBM, and anterior segment SS-OCT.
- Part V: Toward 3D Modeling for Cataracts with Posterior Segment Diseases
- \) Patients with various posterior segment vitreoretinal diseases (e.g., vitreous traction or proliferation, macular hole, epiretinal membrane), with or without anterior segment spatial structural abnormalities; 2) Able to cooperate with and complete relevant examinations including B-scan ultrasound, UBM, and anterior/posterior segment SS-OCT.
- Part VI: Normal Control Group
- No significant structural ocular diseases; 2) Healthy fellow eyes of unilateral ocular trauma patients from Part II, with no notable anterior or posterior segment abnormalities; 3) Able to cooperate with and complete relevant examinations including B-scan ultrasound, UBM, anterior/posterior segment SS-OCT, and CT.
You may not qualify if:
- Part I: Toward 3D Modeling for Lens Disorders Associated with Congenital Anomalies
- \) Concurrent open globe injury or severe ocular deformity; 2) Excessive corneal opacity or severe edema resulting in inadequate image quality; 3) Severe dry eye or tear film abnormalities affecting imaging;4) Severe ocular structural deformity preventing effective 3D model reconstruction; 5) Severe systemic disease precluding tolerance of the examination; 6) Contraindications to B-scan ultrasound or UBM, conditions impairing imaging, or allergy to coupling gel.
- Part II: Toward 3D Modeling for Reconstructive Management of Ocular Trauma
- \) Unmanaged open globe injury or severe ocular deformity; 2) Severe systemic disease precluding tolerance of the examination; 3) Contraindications to CT imaging (e.g., metallic implants in the head/face region, pregnancy, lactation) or history of contrast medium allergy/adverse reactions.
- Part III: Toward 3D Modeling for IOL Spatial Positioning
- \) Unclear IOL position or documented implantation failure; 2) Corneal opacity or severe pupillary abnormality affecting imaging; 3) IOL instability due to intra- or postoperative complications preventing imaging;4) Open globe injury or severe ocular deformity; 5) Severe systemic disease precluding tolerance of the examination; 6) Contraindications to B-scan ultrasound or UBM, conditions impairing imaging, or allergy to coupling gel.
- Part IV: Toward 3D Modeling for Cataracts with Iris/Pupillary Abnormalities
- \) Corneal opacity or hyphema preventing imaging; 2) Severe global ocular deformity precluding imaging; 3) Severe systemic disease precluding tolerance of examination or follow-up; 4) Contraindications to B-scan ultrasound or UBM, conditions impairing imaging, or allergy to coupling gel.
- Part V: Toward 3D Modeling for Cataracts with Posterior Segment Diseases
- \) Severe structural deformity of both anterior and posterior segments preventing effective 3D model reconstruction; 2) Severe systemic disease precluding tolerance of examination or follow-up; 3) Contraindications to B-scan ultrasound or UBM, conditions impairing imaging, or allergy to coupling gel.
- Part VI: Normal Control Group 1) History of severe ocular trauma or ocular surgery; 2) Conditions affecting imaging quality, including corneal opacity, severe dry eye, tear film abnormalities, anterior segment disease, or significant retinal pathology; 3) Severe systemic disease precluding tolerance of the examination; 4) Contraindications to CT imaging (e.g., metallic implants in the head/face region, pregnancy, lactation) or history of contrast medium allergy/adverse reactions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Second Affiliated Hospital, Zhejiang University School of Medicine,
Hangzhou, Zhejiang, 310009, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wen Xu, Phd
Second Affiliated Hospital, School of Medicine, Zhejiang University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 7, 2025
First Posted
January 7, 2026
Study Start
January 1, 2020
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
January 7, 2026
Record last verified: 2025-11